Found 17 matching trials
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation
PHASE1This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Status
Active Not Recruiting
Location
Childrens National Medical Center
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection
PHASE2This phase II trial studies how well donor cytomegalovirus-specific cytotox...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
CMV-CTL for the Treatment of CMV Infection After HSCT
PHASE4Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
PHASE1This phase I/II trial studies the safety and toxicity of post-transplant tr...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT
PHASE1Human cytomegalovirus (CMV) is a benign infectious agent in the normal host...
Location
Duke University Medical Center
Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV
PHASE1The primary purpose of this phase I/II study is to evaluate whether partial...
Location
UPMC (University of Pittsburgh Medical Center)
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_PHASE1This trial studies the side effects and how well allogeneic cytomegalovirus...
Location
Nationwide Children's Hospital
Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients
PHASE1Marrow transplanted immunocompromised patients with cytomegalovirus (CMV) v...
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
PHASE2RATIONALE: An infusion of cytomegalovirus-specific T lymphocytes may preven...
Location
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust
Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
PHASE1PIDD represent an expanding group of genetic disorders that compromise immu...
Location
Childrens National Medical Center